This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Scorpio Tankers (STNG) Moves 9.2% Higher: Will This Strength Last?
by Zacks Equity Research
Scorpio Tankers (STNG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
STNGNegative Net Change ECONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
MP Materials (MP) Moves 50.6% Higher: Will This Strength Last?
by Zacks Equity Research
MP Materials (MP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MPPositive Net Change TECKNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Group 1 Automotive (GPI) Soars 3.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Group 1 Automotive (GPI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
GPIPositive Net Change ANPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Piper Sandler Companies (PIPR) Stock Jumps 4.4%: Will It Continue to Soar?
by Zacks Equity Research
Piper Sandler Companies (PIPR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
PIPRPositive Net Change CPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
CSW Industrials (CSW) Stock Jumps 3.6%: Will It Continue to Soar?
by Zacks Equity Research
CSW Industrials (CSW) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CSWPositive Net Change BCPCNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Rhythm Pharmaceuticals (RYTM) Stock Jumps 36.6%: Will It Continue to Soar?
by Zacks Equity Research
Rhythm Pharmaceuticals (RYTM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CSWPositive Net Change BCPCNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Beam Therapeutics (BEAM) Surges 5.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Beam Therapeutics (BEAM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CSWPositive Net Change BCPCNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Shore Bancshares (SHBI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
SHBIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Origin Bancorp (OBK) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
OBKPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Newmont Corporation (NEM) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
NEMNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Vir Biotechnology (VIR) Soars 11.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Vir Biotechnology (VIR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
VIRNegative Net Change IRDNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Ultragenyx (RARE) Surges 5.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
Ultragenyx (RARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RARENegative Net Change FBIONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
TopBuild (BLD) Surges 6.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
TopBuild (BLD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RARENegative Net Change FBIONegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
PTC Inc. (PTC) Soars 17.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
PTC Inc. (PTC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RARENegative Net Change FBIONegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
XPLR Infrastructure (XIFR) Surges 16.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
XPLR Infrastructure (XIFR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RARENegative Net Change FBIONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Freightcar America (RAIL) Moves 18.6% Higher: Will This Strength Last?
by Zacks Equity Research
Freightcar America (RAIL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
RARENegative Net Change FBIONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
CRISPR Therapeutics (CRSP) Moves 9.6% Higher: Will This Strength Last?
by Zacks Equity Research
CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
RARENegative Net Change FBIONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Agios Pharmaceuticals (AGIO) Moves 7.7% Higher: Will This Strength Last?
by Zacks Equity Research
Agios Pharmaceuticals (AGIO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RARENegative Net Change FBIONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
HighPeak Energy (HPK) Surges 7.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
HighPeak Energy (HPK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
HPKPositive Net Change PRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
BTCS Inc. (BTCS) Stock Jumps 111.1%: Will It Continue to Soar?
by Zacks Equity Research
BTCS Inc. (BTCS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
BTCSPositive Net Change PDLBPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Valero Energy (VLO) Moves 3.4% Higher: Will This Strength Last?
by Zacks Equity Research
Valero Energy (VLO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
VLOPositive Net Change WKCPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Korn/Ferry (KFY) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
KFYPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Dell Technologies (DELL) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
DELLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, East West Bancorp (EWBC)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
EWBCPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Industrial Logistics Properties Trust (ILPT) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
ILPTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines